216 related articles for article (PubMed ID: 29462386)
1. Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
Zhou F; Hamza T; Fleur AS; Zhang Y; Yu H; Chen K; Heath JE; Chen Y; Huang H; Feng H
Inflamm Bowel Dis; 2018 Feb; 24(3):573-582. PubMed ID: 29462386
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
4. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
[TBL] [Abstract][Full Text] [Related]
8. Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1/mTOR in mice.
Wang S; Deng W; Li F; Xiang L; Lv P; Chen Y
J Nutr Biochem; 2023 Jan; 111():109155. PubMed ID: 36162566
[TBL] [Abstract][Full Text] [Related]
9. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
[TBL] [Abstract][Full Text] [Related]
10. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease from a teaching hospital.
Li YM; Liao JZ; Jian ZJ; Li HL; Chen X; Liu QX; Liu PL; Wang ZQ; Liu X; Yan Q; Liu WE
J Clin Lab Anal; 2022 Dec; 36(12):e24773. PubMed ID: 36397282
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection and inflammatory bowel disease: what gastroenterologists and surgeons should know.
Cojocariu C; Trifan A; Stoica O; Chihaia CA; Stanciu C
Chirurgia (Bucur); 2014; 109(5):579-83. PubMed ID: 25532244
[TBL] [Abstract][Full Text] [Related]
13. Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease.
Bushman FD; Conrad M; Ren Y; Zhao C; Gu C; Petucci C; Kim MS; Abbas A; Downes KJ; Devas N; Mattei LM; Breton J; Kelsen J; Marakos S; Galgano A; Kachelries K; Erlichman J; Hart JL; Moraskie M; Kim D; Zhang H; Hofstaedter CE; Wu GD; Lewis JD; Zackular JP; Li H; Bittinger K; Baldassano R
Cell Host Microbe; 2020 Sep; 28(3):422-433.e7. PubMed ID: 32822584
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: Clostridium difficile and inflammatory bowel disease.
Goodhand JR; Alazawi W; Rampton DS
Aliment Pharmacol Ther; 2011 Feb; 33(4):428-41. PubMed ID: 21198703
[TBL] [Abstract][Full Text] [Related]
18. Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.
Reasoner SA; Nicholson MR
Curr Gastroenterol Rep; 2023 Nov; 25(11):316-322. PubMed ID: 37646895
[TBL] [Abstract][Full Text] [Related]
19. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
[TBL] [Abstract][Full Text] [Related]
20. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
Aliment Pharmacol Ther; 2014 May; 39(10):1136-42. PubMed ID: 24641590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]